Editor’s note

Concerned with declining pharma exports in the recent past, the Ministry of Commerce & Industry has tried to burnish the brand…

A notice dated March 30 from the Drug Controller General (India) asking for ‘science-based suggestions/ comments’ on the pros and…

Manufacturing quality has now become probably the single most important concern in the boardrooms of pharmaceutical companies in…

The fixed dose combination (FDC) issue has been a contentious one for years and on March 10 came back to haunt pharma companies in…

In his third budget, Finance Minister Arun Jaitley has taken one more shot at a balancing act between maintaining fiscal…

As we mark yet another Women’s Day this March, here are some sobering words from Sanghita Bhattacharyya, Senior Public Health…

Precious things come in small packages (think diamonds)

All eyes are once again on India's Finance Minister Arun Jaitley as he prepares to present the Modi Government's second full…

I’d hazard a guess that there is hardly anyone who is not a user of e-commerce platforms to ease the daily grind

A new year brings with it new hope but all indications are that 2016 is going to be a mixed bag for the pharmaceutical industry

Could New Jersey Superior Court's decision this October be a wake up call for Indian companies with global ambitions

If the latest edition of the Antal Global Snapshot (AGS) on annual global hiring and firing trends is any indicator, hiring in…

In our last issue, we highlighted Swati Spentose’s quiet rise to become a Rs 40-crore speciality API manufacturer

Vishal Jajodia could sign up as a poster boy for Prime Minister Narendra Modi's Make In India campaign

Besides the balanced reasoning within the Delhi HC judgement, it is the SC's intervention which could see this case go down as a…

The last month saw a major milestone in the patent versus patient debate

According to the latest data from the India Brand Equity Foundation (IBEF), the Indian domestic pharma market ended FY15 with a…

Some industry observers are surprised that ‘significant violations’ of this nature have not warranted an import alert or ban

After a decade of pain, there are some reassuring signs that the pharmaceutical industry may just be seeing the faint glimmers of…

With the launch of the Digital India campaign in early July, it is time to relook India Pharma Inc’s engagement with technology